Top

Published in:

01-07-2015 | Original Contribution

C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation

Authors: Hong Lei, Dan Wu, Jin-Yu Wang, Li Li, Cheng-Lin Zhang, Han Feng, Feng-Ying Fu, Li-Ling Wu

Published in: Basic Research in Cardiology | Issue 4/2015

Abstract

C1q/tumor necrosis factor-related protein-6 (CTRP6) is a newly identified adiponectin paralog with modulation effects on metabolism and inflammation. However, the cardiovascular function of CTRP6 remains unknown. This study aimed to determine its role in cardiac fibrosis and explore the possible mechanism. Myocardial infarction (MI) was induced by left anterior descending coronary artery ligation in rats. CTRP6 was mainly expressed in the cytoplasm of adult rat cardiomyocytes and significantly decreased in the border and infarct zones post-MI. Adenovirus-mediated CTRP6 delivery improved cardiac function, attenuated cardiac hypertrophy, alleviated cardiac fibrosis, and inhibited myofibroblast differentiation as well as the expression of collagen I, collagen III, and connective tissue growth factor post-MI. In cultured adult rat cardiac fibroblasts (CFs), exogenous or cardiomyocyte-secreted CTRP6 inhibited, whereas knockdown of CTRP6 facilitated transforming growth factor-β1 (TGF-β1)-induced expression of α-smooth muscle actin, smooth muscle 22α, and profibrotic molecules. CTRP6 had no effect on CFs proliferation but attenuated CFs migration induced by TGF-β1. CTRP6 increased the phosphorylation of AMP-activated protein kinase (AMPK) and Akt in CFs and post-MI hearts. Pretreatment with adenine 9-β-d-arabinofuranoside (AraA), an AMPK inhibitor, or LY294002, a phosphatidylinositol-3-kinase (PI3 K) inhibitor, abolished the protective effect of CTRP6 on TGF-β1-induced profibrotic response. Furthermore, CTRP6 had no effect on TGF-β1-induced Smad3 phosphorylation and nuclear translocation, whereas significantly decreased TGF-β1-induced RhoA activation and myocardin-related transcription factor-A (MRTF-A) nuclear translocation, and these effects were blocked by AMPK or Akt inhibition. In conclusion, CTRP6 attenuates cardiac fibrosis via inhibiting myofibroblast differentiation. AMPK and Akt activation are responsible for the CTRP6-mediated anti-fibrotic effect by targeting RhoA/MRTF-A pathway.

Available only for authorised users

Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-beta signaling in fibrosis. Growth Factors 29:196–202. doi:10.3109/08977194.2011.595714 PubMedCentralPubMedCrossRef

Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184–195. doi:10.1016/j.cardiores.2006.10.002 PubMedCentralPubMedCrossRef

Cao T, Gao Z, Gu L, Chen M, Yang B, Cao K, Huang H, Li M (2014) AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS One 9:e103793. doi:10.1371/journal.pone.0103793 PubMedCentralPubMedCrossRef

Cavin S, Maric D, Diviani D (2014) A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts. Biochim Biophys Acta 1843:335–345. doi:10.1016/j.bbamcr.2013.11.008 PubMedCrossRef

Cieslik KA, Taffet GE, Crawford JR, Trial J, Mejia Osuna P, Entman ML (2013) AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J Mol Cell Cardiol 63:26–36. doi:10.1016/j.yjmcc.2013.07.005 PubMedCrossRef

Crider BJ, Risinger GM Jr, Haaksma CJ, Howard EW, Tomasek JJ (2011) Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J Invest Dermatol 131:2378–2385. doi:10.1038/jid.2011.219 PubMedCentralPubMedCrossRef

Davis J, Molkentin JD (2014) Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol 70:9–18. doi:10.1016/j.yjmcc.2013.10.019 PubMedCrossRef

Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG (2010) Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 107:418–428. doi:10.1161/CIRCRESAHA.109.216101 PubMedCentralPubMedCrossRef

Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 51:600–606. doi:10.1016/j.yjmcc.2010.10.033 PubMedCentralPubMedCrossRef

10.

Fu YN, Xiao H, Ma XW, Jiang SY, Xu M, Zhang YY (2011) Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. Acta Pharmacol Sin 32:879–887. doi:10.1038/aps.2010.229 PubMedCentralPubMedCrossRef

11.

Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T (2008) Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol 28:863–870. doi:10.1161/ATVBAHA.107.156687 PubMedCrossRef

12.

Fujiu K, Nagai R (2013) Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development. Basic Res Cardiol 108:357. doi:10.1007/s00395-013-0357-x PubMedCrossRef

13.

Guo J, Bian Y, Bai R, Li H, Fu M, Xiao C (2013) Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress. J Cardiovasc Pharmacol 62:143–153. doi:10.1097/FJC.0b013e31829521af PubMedCrossRef

14.

Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. doi:10.1016/S0140-6736(14)60107-0 PubMedCentralPubMedCrossRef

15.

Hofmann C, Chen N, Obermeier F, Paul G, Buechler C, Kopp A, Falk W, Schaffler A (2011) C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflamm Bowel Dis 17:2462–2471. doi:10.1002/ibd.21647 PubMedCrossRef

16.

Kakkar R, Lee RT (2010) Intramyocardial fibroblast myocyte communication. Circ Res 106:47–57. doi:10.1161/CIRCRESAHA.109.207456 PubMedCentralPubMedCrossRef

17.

Kambara T, Ohashi K, Shibata R, Ogura Y, Maruyama S, Enomoto T, Uemura Y, Shimizu Y, Yuasa D, Matsuo K, Miyabe M, Kataoka Y, Murohara T, Ouchi N (2012) CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem 287:18965–18973. doi:10.1074/jbc.M112.357939 PubMedCentralPubMedCrossRef

18.

Kim M, Tian R (2011) Targeting AMPK for cardiac protection: opportunities and challenges. J Mol Cell Cardiol 51:548–553. doi:10.1016/j.yjmcc.2010.12.004 PubMedCentralPubMedCrossRef

19.

Kim MJ, Lee W, Park EJ, Park SY (2010) C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages. Mol Cells 30:59–64. doi:10.1007/s10059-010-0088-x PubMedCrossRef

20.

Kleinbongard P, Schulz R, Heusch G (2011) TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev 16:49–69. doi:10.1007/s10741-010-9180-8 PubMedCrossRef

21.

Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549–574. doi:10.1007/s00018-013-1349-6 PubMedCentralPubMedCrossRef

22.

Lajiness JD, Conway SJ (2014) Origin, development, and differentiation of cardiac fibroblasts. J Mol Cell Cardiol 70:2–8. doi:10.1016/j.yjmcc.2013.11.003 PubMedCrossRef

23.

Lee W, Kim MJ, Park EJ, Choi YJ, Park SY (2010) C1qTNF-related protein-6 mediates fatty acid oxidation via the activation of the AMP-activated protein kinase. FEBS Lett 584:968–972. doi:10.1016/j.febslet.2010.01.040 PubMedCrossRef

24.

Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, Zhou Y, Wu LL (2011) Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 91:80–89. doi:10.1093/cvr/cvr067 PubMedCrossRef

25.

Li L, Zhang ZG, Lei H, Wang C, Wu LP, Wang JY, Fu FY, Zhu WG, Wu LL (2013) Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway. PLoS One 8:e49915. doi:10.1371/journal.pone.0049915 PubMedCentralPubMedCrossRef

26.

Morrison A, Li J (2011) PPAR-gamma and AMPK–advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol 82:195–200. doi:10.1016/j.bcp.2011.04.004 PubMedCrossRef

27.

Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J (2000) Leptin attenuates cardiac contraction in rat ventricular myocytes role of NO. Hypertension 36:501–505. doi:10.1161/01.HYP.36.4.501 PubMedCrossRef

28.

Ouchi N, Shibata R, Walsh K (2006) Cardioprotection by adiponectin. Trends Cardiovasc Med 16:141–146. doi:10.1016/j.tcm.2006.03.001 PubMedCentralPubMedCrossRef

29.

Pol CJ, Muller A, Zuidwijk MJ, van Deel ED, Kaptein E, Saba A, Marchini M, Zucchi R, Visser TJ, Paulus WJ, Duncker DJ, Simonides WS (2011) Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology 152:669–679. doi:10.1210/en.2010-0431 PubMedCrossRef

30.

Rahaman SO, Grove LM, Paruchuri S, Southern BD, Abraham S, Niese KA, Scheraga RG, Ghosh S, Thodeti CK, Zhang DX, Moran MM, Schilling WP, Tschumperlin DJ, Olman MA (2014) TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest 124:5225–5238. doi:10.1172/JCI75331 PubMedCentralPubMedCrossRef

31.

Schäffler A, Buechler C (2012) CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 23:194–204. doi:10.1016/j.tem.2011.12.003 PubMedCrossRef

32.

Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, Sam F, Ouchi N, Walsh K (2007) Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42:1065–1074. doi:10.1016/j.yjmcc.2007.03.808 PubMedCentralPubMedCrossRef

33.

Small EM (2012) The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 5:794–804. doi:10.1007/s12265-012-9397-0 PubMedCrossRef

34.

Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, Olson EN (2010) Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107:294–304. doi:10.1161/CIRCRESAHA.110.223172 PubMedCentralPubMedCrossRef

35.

Su H, Yuan Y, Wang XM, Lau WB, Wang Y, Wang X, Gao E, Koch WJ, Ma XL (2013) Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFalpha-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice. Basic Res Cardiol 108:315. doi:10.1007/s00395-012-0315-z PubMedCrossRef

36.

Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K, Kodama I (2010) Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 86:113–121. doi:10.1093/cvr/cvp386 PubMedCrossRef

37.

Sun Y, Yi W, Yuan Y, Lau WB, Yi D, Wang X, Wang Y, Su H, Gao E, Koch WJ, Ma XL (2013) C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation. Circulation 128:S113–S120. doi:10.1161/CIRCULATIONAHA.112.000010 PubMedCrossRef

38.

Sussman MA, Volkers M, Fischer K, Bailey B, Cottage CT, Din S, Gude N, Avitabile D, Alvarez R, Sundararaman B, Quijada P, Mason M, Konstandin MH, Malhowski A, Cheng Z, Khan M, McGregor M (2011) Myocardial AKT: the omnipresent nexus. Physiol Rev 91:1023–1070. doi:10.1152/physrev.00024.2010 PubMedCentralPubMedCrossRef

39.

Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–2988. doi:10.1161/01.CIR.101.25.2981 PubMedCrossRef

40.

Takeuchi T, Adachi Y, Nagayama T (2011) Expression of a secretory protein C1qTNF6, a C1qTNF family member, in hepatocellular carcinoma. Anal Cell Pathol (Amst) 34:113–121. doi:10.3233/ACP-2011-009 CrossRef

41.

Tseliou E, Reich H, de Couto G, Terrovitis J, Sun B, Liu W, Marban E (2014) Cardiospheres reverse adverse remodeling in chronic rat myocardial infarction: roles of soluble endoglin and Tgf-beta signaling. Basic Res Cardiol 109:443. doi:10.1007/s00395-014-0443-8 PubMedCrossRef

42.

Tullio F, Angotti C, Perrelli MG, Penna C, Pagliaro P (2013) Redox balance and cardioprotection. Basic Res Cardiol 108:392. doi:10.1007/s00395-013-0392-7 PubMedCrossRef

43.

van Nieuwenhoven FA, Turner NA (2013) The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 58:182–188. doi:10.1016/j.vph.2012.07.003 PubMedCrossRef

44.

Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li R, Wang X, Koch WJ, Ma XL (2010) Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 298:E663–E670. doi:10.1152/ajpendo.00663.2009 PubMedCentralPubMedCrossRef

45.

Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF (2008) Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 416:161–177. doi:10.1042/BJ20081240 PubMedCentralPubMedCrossRef

46.

Wu WJ, Mo L, Zhao CZ, Zhao C, Chen YS, Pang WJ, Yang GS (2015) Knockdown of CTRP6 inhibits adipogenesis via lipogenic marker genes and Erk1/2 signalling pathway. Cell Biol Int 39:554–562. doi:10.1002/cbin.10422 PubMedCrossRef

47.

Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang X, Wang Y, Shang X, Gao E, Koch WJ, Ma XL (2012) C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation 125:3159–3169. doi:10.1161/CIRCULATIONAHA.112.099937 PubMedCentralPubMedCrossRef

48.

Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G, Jiang X (2014) Hepatocyte growth factor regulates the TGF-beta1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med 34:381–390. doi:10.3892/ijmm.2014.1782 PubMedCentralPubMed

49.

Zhang P, Su J, Mende U (2012) Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. Am J Physiol Heart Circ Physiol 303:H1385–H1396. doi:10.1152/ajpheart.01167.2011 PubMedCentralPubMedCrossRef

50.

Zhang YJ, Yang SH, Li MH, Iqbal J, Bourantas CV, Mi QY, Yu YH, Li JJ, Zhao SL, Tian NL, Chen SL (2014) Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy. Clin Exp Pharmacol Physiol 41:995–1002. doi:10.1111/1440-1681.12309 PubMedCrossRef

51.

Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL (2014) Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Arterioscler Thromb Vasc Biol 34:1002–1010. doi:10.1161/ATVBAHA.114.303301 PubMedCrossRef

Title: C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation
Authors: Hong Lei
Dan Wu
Jin-Yu Wang
Li Li
Cheng-Lin Zhang
Han Feng
Feng-Ying Fu
Li-Ling Wu
Publication date: 01-07-2015
Publisher: Springer Berlin Heidelberg
Published in: Basic Research in Cardiology / Issue 4/2015
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-015-0492-7

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Nuclear cardiac myosin light chain 2 modulates NADPH oxidase 2 expression in myocardium: a novel function beyond muscle contraction

Irregular rhythm and atrial metabolism are key for the evolution of proarrhythmic atrial remodeling in atrial fibrillation

Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling

SIRT3 deficiency impairs mitochondrial and contractile function in the heart

Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice

The Ca2+-activated cation channel TRPM4 is a negative regulator of angiotensin II-induced cardiac hypertrophy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page